Biomarkers in medicine最新文献

筛选
英文 中文
Serum vitamin D, hemoglobin A1c and vitamin B12 levels in patients with gingivitis and periodontitis stages 牙龈炎和牙周炎阶段患者的血清维生素 D、血红蛋白 A1c 和维生素 B12 水平
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-05-15 DOI: 10.1080/17520363.2024.2342236
Selcen Ozcan Bulut, Deniz Noyun, Sebnem Dirikan İpci, Gokser Cakar
{"title":"Serum vitamin D, hemoglobin A1c and vitamin B12 levels in patients with gingivitis and periodontitis stages","authors":"Selcen Ozcan Bulut, Deniz Noyun, Sebnem Dirikan İpci, Gokser Cakar","doi":"10.1080/17520363.2024.2342236","DOIUrl":"https://doi.org/10.1080/17520363.2024.2342236","url":null,"abstract":"<p><b>Aim:</b> To compare the serum vitamin D, hemoglobin A1c (HbA1c) and vitamin B12 levels in patients with gingivitis and four different periodontitis stages diagnosed according to the 2017 Periodontal Disease Classification. <b>Materials &amp; methods:</b> A total of 606 patients were included in the study who were diagnosed with gingivitis and stage I–IV periodontitis. Patients were divided into groups based on disease stage, and the HbA1c, vitamin D and B12 levels of the patients were compared and analyzed. <b>Result:</b> The highest HbA1c level and the lowest vitamin D level were seen in stage III–IV periodontitis. The highest vitamin D and B12 levels were seen in the gingivitis group. <b>Conclusion:</b> Serum HbA1c, vitamin D and B12 levels might vary depending on the presence or severity of periodontitis.</p><p><b>Clinical Trial Registration:</b> NCT05745779 (This study was registered and approved by www.clinicaltrials.gov)</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"1 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140941529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C-reactive protein to albumin ratio and radial artery thrombosis post transradial angiography 经桡动脉血管造影术后 C 反应蛋白与白蛋白比率和桡动脉血栓形成
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-05-15 DOI: 10.1080/17520363.2024.2345578
Serkan Bulguroglu, Yunus Calapkulu, Ural Koc, Mehmet Erdogan, Zehra Gölbası
{"title":"C-reactive protein to albumin ratio and radial artery thrombosis post transradial angiography","authors":"Serkan Bulguroglu, Yunus Calapkulu, Ural Koc, Mehmet Erdogan, Zehra Gölbası","doi":"10.1080/17520363.2024.2345578","DOIUrl":"https://doi.org/10.1080/17520363.2024.2345578","url":null,"abstract":"<p><b>Aim:</b> The aim is to evaluate the relationship between C-reactive protein (CRP) to albumin ratio (CAR) and radial artery thrombosis in patients undergoing radial angiography. <b>Patients &amp; methods:</b> We prospectively included 261 consecutive patients undergoing radial angiography, assessing radial artery diameter and thrombosis presence. <b>Results:</b> The CRP values were significantly higher in radial artery thrombosis group compared with group without thrombosis (13.01 vs. 4.33 mg/l, p &lt; 0.001, respectively). Also CAR was statistically significantly different between the group with thrombosis and the group without thrombosis (0.102 vs. 0.349, p &lt; 0.001). <b>Conclusion:</b> Our study is the first to assess CAR in radial thrombus development post-procedure in patients undergoing radial angiography. CAR can be useful in determining radial artery thrombosis after the coronary angiography.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"66 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140941604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting cerebral infarction in tuberculous meningitis and its prognostic significance 结核性脑膜炎脑梗塞的预测及其预后意义
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-05-15 DOI: 10.1080/17520363.2024.2347194
Asha Aggrohia, Vikas Bhatia, Atul Saroch, Ashok Kumar Pannu
{"title":"Predicting cerebral infarction in tuberculous meningitis and its prognostic significance","authors":"Asha Aggrohia, Vikas Bhatia, Atul Saroch, Ashok Kumar Pannu","doi":"10.1080/17520363.2024.2347194","DOIUrl":"https://doi.org/10.1080/17520363.2024.2347194","url":null,"abstract":"<p><b>Aim:</b> Tuberculous meningitis (TBM) often causes cerebral infarction, but its predictive factors are not well understood. <b>Methods:</b> Patients aged ≥13 years admitted with TBM were enrolled prospectively. Cerebral infarction was diagnosed using magnetic resonance imaging. <b>Results:</b> Of 186 patients, 80 (43%) had infarction. Most infarctions were multiple and located in the cortical areas, basal ganglia and subcortical regions. Independent predictors of infarction at admission included high blood pressure, short illness duration, low Glasgow coma scale and hydrocephalus. Neuroimaging inflammation signs, cerebrospinal fluid analysis abnormalities and pre-existing cardiovascular risks did not predict infarction. In-hospital mortality was higher in TBM with infarction, particularly in those with advanced TBM (stage 3). <b>Conclusion:</b> Baseline parameters of raised intracranial pressure predict cerebral infarction in TBM.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"122 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140941670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of inflammation markers in occurrence of radial artery occlusion 炎症标志物在桡动脉闭塞发生中的作用
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-05-15 DOI: 10.1080/17520363.2024.2345582
Saadet Demirtas Inci, Huseyin Gunduz, Yasemin Gunduz
{"title":"The role of inflammation markers in occurrence of radial artery occlusion","authors":"Saadet Demirtas Inci, Huseyin Gunduz, Yasemin Gunduz","doi":"10.1080/17520363.2024.2345582","DOIUrl":"https://doi.org/10.1080/17520363.2024.2345582","url":null,"abstract":"<p><b>Aim:</b> Radial artery occlusion (RAO) is a major complication of catheterization via transradial access (TRA). Our aim is to reveal the ability of high-sensitive C-reactive protein (hs-CRP) and complete blood count (CBC) components, which are inflammation markers, to predict RAO. <b>Methods:</b> Patients were divided into two groups: 103 with RAO and 300 without RAO. The relationship between CRP, CBC components and RAO was evaluated. <b>Results:</b> A significant increase in hs-CRP, monocyte, platelet (PLT), platelet distribution width (PDW) and plateletcrit values was observed after TRA, and only the increase in PDW, PLT and hs-CRP was found to be independent determinants in regression analysis. <b>Conclusion:</b> High PDW and PLT and increased hs-CRP levels are new independent determinants of the development of RAO.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"32 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140941539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of PD-L1 expression in patients with anal cancer: a meta-analysis 肛门癌患者 PD-L1 表达的预后价值:一项荟萃分析
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-05-03 DOI: 10.2217/bmm-2023-0727
Siqi Gong, Jiafeng Song
{"title":"Prognostic value of PD-L1 expression in patients with anal cancer: a meta-analysis","authors":"Siqi Gong, Jiafeng Song","doi":"10.2217/bmm-2023-0727","DOIUrl":"https://doi.org/10.2217/bmm-2023-0727","url":null,"abstract":"<p><b>Background:</b> The present meta-analysis was performed to evaluate the prognostic and clinicopathological significance of PD-L1 in anal cancer (AC). <b>Methods:</b> Hazard ratios (HRs) and 95% CIs regarding overall survival (OS) and progression-free survival (PFS) were calculated based on PD-L1 levels. <b>Results:</b> According to the combined data, PD-L1 showed no significant relationship with OS (HR = 0.76; 95% CI = 0.35–1.67; p = 0.502) or PFS (HR = 0.88; 95% CI = 0.35–2.33; p = 0.789) in patients with AC. Based on subgroup analysis, PD-L1 overexpression significantly predicted prolonged OS (HR = 0.38; 95% CI = 0.17–0.84; p = 0.017) in tumor node metastasis stages I–III and inferior PFS (HR = 2.73; 95% CI = 1.32–5.65; p = 0.007) in patients with stage I–IV AC. <b>Conclusion:</b> PD-L1 level assessed by immunohistochemistry did not significantly predict survival outcomes in AC cases.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"4 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140828412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of triglyceride-glucose index for left ventricular remodeling in nondiabetic ST-elevation myocardial infarction patients 甘油三酯-葡萄糖指数对非糖尿病 ST 段抬高型心肌梗死患者左心室重构的预后价值
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-04-19 DOI: 10.2217/bmm-2024-0015
Tolga Han Efe, Engin Algül
{"title":"Prognostic value of triglyceride-glucose index for left ventricular remodeling in nondiabetic ST-elevation myocardial infarction patients","authors":"Tolga Han Efe, Engin Algül","doi":"10.2217/bmm-2024-0015","DOIUrl":"https://doi.org/10.2217/bmm-2024-0015","url":null,"abstract":"<p><b>Background:</b> The triglyceride-glucose (TyG) index is a marker of insulin resistance and is associated with cardiovascular mortality and morbidity. Left ventricular remodeling (LVR) after myocardial infarction (STEMI) is associated with poor prognosis. <b>Methods:</b> This retrospective study included 293 STEMI patients. Echocardiography was performed before discharge and 3 months after MI. <b>Results:</b> Compared with the non-LVR group, TyG index value was found to be higher in the LVR group (p &lt; 0.001). Logistic regression analysis showed that higher maximal troponin I value, higher calculated TyG index value, higher N-terminal prohormone of brain natriuretic peptide level and the presence of anterior MI were independently associated with the development of LVR. <b>Conclusion:</b> A high TyG index level may contribute to the prediction of LVR in nondiabetic STEMI patients undergoing successful primary percutaneous coronary intervention.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"27 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140631140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic role of C-reactive protein in patients with endometrial cancer: a meta-analysis 子宫内膜癌患者 C 反应蛋白的预后作用:一项荟萃分析
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-04-19 DOI: 10.2217/bmm-2023-0810
Xieyan Yu, Xiaoxing Zhang
{"title":"Prognostic role of C-reactive protein in patients with endometrial cancer: a meta-analysis","authors":"Xieyan Yu, Xiaoxing Zhang","doi":"10.2217/bmm-2023-0810","DOIUrl":"https://doi.org/10.2217/bmm-2023-0810","url":null,"abstract":"<p><b>Background:</b> The present meta-analysis aimed to explore the association between C-reactive protein (CRP) levels and the prognosis of patients with endometrial cancer (EC). <b>Methods:</b> The effect of CRP level on predicting overall survival (OS) and disease-free survival (DFS) in patients with EC was evaluated according to pooled hazard ratios (HRs) and corresponding 95% CIs. <b>Results:</b> High CRP levels were not significantly correlated with OS (HR: 1.32 [95% CI: 0.99–1.77]; p = 0.060) or DFS (HR: 1.05 [95% CI: 0.88–1.25]; p = 0.597) in patients with EC. <b>Conclusion:</b> CRP levels did not significantly predict OS or DFS in patients with EC. However, according to subgroup analyses, higher CRP levels were significantly associated with poor OS in Asian patients with EC.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"40 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140628022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PLK3 is linked with higher tumor stage and unfavorable prognosis in patients with colorectal cancer PLK3 与结直肠癌患者较高的肿瘤分期和不利的预后有关
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-04-17 DOI: 10.2217/bmm-2023-0591
Hai Zeng, Qian Wang, Ying Xiang, Yameng Yang, Xia Tu, Hui He, Shuang Li, Weijia Zhang
{"title":"PLK3 is linked with higher tumor stage and unfavorable prognosis in patients with colorectal cancer","authors":"Hai Zeng, Qian Wang, Ying Xiang, Yameng Yang, Xia Tu, Hui He, Shuang Li, Weijia Zhang","doi":"10.2217/bmm-2023-0591","DOIUrl":"https://doi.org/10.2217/bmm-2023-0591","url":null,"abstract":"<p><b>Objective:</b> This study intended to explore the relationship of PLK3 with prognosis in patients with colorectal cancer (CRC). <b>Methods:</b> PLK3 positivity was detected by immunohistochemistry in 160 patients with CRC receiving surgical resection. <b>Results:</b> The median tumor PLK3-positive rate was 26.5%. Tumor PLK3-positive rate was related to increased lymph node stage (p = 0.002) and tumor–node–metastasis stage (p &lt; 0.001) of CRC. Tumor PLK3-positive rate ≥30% was related to shortened disease-free survival (p = 0.009) and overall survival (p = 0.003); tumor PLK3-positive rate ≥50% showed a stronger correlation with them (both p = 0.001), which was validated by multivariate Cox regression analyses (both p &lt; 0.05). <b>Conclusion:</b> Tumor PLK3-positive rate ≥50% relates to increased tumor stage and unfavorable survival in patients with CRC.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"48 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140615669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of pretreatment systemic immune-inflammation index in patients with endometrial cancer: a meta-analysis 子宫内膜癌患者治疗前全身免疫炎症指数的预后价值:一项荟萃分析
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-04-16 DOI: 10.2217/bmm-2023-0629
Pengtian Ji, Junjun He
{"title":"Prognostic value of pretreatment systemic immune-inflammation index in patients with endometrial cancer: a meta-analysis","authors":"Pengtian Ji, Junjun He","doi":"10.2217/bmm-2023-0629","DOIUrl":"https://doi.org/10.2217/bmm-2023-0629","url":null,"abstract":"<p><b>Background:</b> The present work focused on evaluating the systemic immune-inflammation index (SII) for its role in predicting endometrial cancer (EC) patient prognosis by meta-analysis. <b>Methods:</b> SII's role in predicting the prognosis of EC patients was analyzed by calculating combined hazard ratios (HRs) and 95% CIs. <b>Results:</b> As revealed by combined analysis, an increased SII predicted poor overall survival (HR = 2.01; 95% CI = 1.58–2.57; p &lt; 0.001) as well as inferior progression-free survival (HR = 1.87; 95% CI = 1.36–2.58; p &lt; 0.001) of EC. <b>Conclusion:</b> An increased SII score significantly predicted poor overall survival and progression-free survival in subjects with EC. The SII is suitable for predicting short- and long-term prognoses of patients with EC.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"94 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140578473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring novel perspectives on eosinophilic inflammation in severe asthma 探索重症哮喘中嗜酸性粒细胞炎症的新视角
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-04-16 DOI: 10.2217/bmm-2023-0801
Claudio Candia, Pasquale Ambrosino, Silvestro E D’Anna, Andrea Motta, Mauro Maniscalco
{"title":"Exploring novel perspectives on eosinophilic inflammation in severe asthma","authors":"Claudio Candia, Pasquale Ambrosino, Silvestro E D’Anna, Andrea Motta, Mauro Maniscalco","doi":"10.2217/bmm-2023-0801","DOIUrl":"https://doi.org/10.2217/bmm-2023-0801","url":null,"abstract":"<p>Two recent articles by the same research group documented that patients with severe eosinophilic asthma exhibit an increased proportion of a subtype of eosinophils, namely CD62L<sup>low</sup> inflammatory eosinophils (iEos) and identified an intriguing correlation between such iEos and asthma control scores. Moreover, CD62L<sup>low</sup> iEos were reduced after treatment with the anti-IL-5 monoclonal antibody mepolizumab. In the future, we believe that eosinophil subtypes could represent a useful biomarker in severe eosinophilic asthma, helping clinicians characterize patient endotypes and monitoring the response to biological drugs.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"86 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140578001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信